Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1544187

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1544187

In Vitro Fertilization Market Size, Share, Growth Analysis, By Cycle (Fresh Non-Donor, Frozen Non-Donor), By Procedure (Conventional IVF, IVF with Donar Eggs), By End-use (Fertility Clinics, Hospitals), By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global In Vitro Fertilization Market size was valued at USD 24.20 Billion in 2022 and is poised to grow from USD 26.09 Billion in 2023 to USD 47.54 Billion by 2031, at a CAGR of 7.79% during the forecast period (2024- 2031).

The global in vitro fertilization (IVF) market encompasses the field of assisted reproductive technology (ART), where egg fertilization occurs outside the human body. IVF has become a prominent method for addressing infertility and helping couples achieve pregnancy. The process typically includes ovarian stimulation, egg retrieval, fertilization, and embryo transfer. The primary aim of the IVF market is to provide solutions for couples struggling with fertility issues, offering them a pathway to successful conception when natural methods are insufficient or unlikely to succeed. Increasing global infertility rates, driven by factors such as lifestyle changes, delayed childbearing, hormonal disorders, and medical conditions, have intensified the demand for IVF. Technological advancements in IVF-such as enhanced laboratory techniques, improved cryopreservation methods, and advanced genetic testing-have significantly boosted success rates. These improvements have attracted couples seeking reliable fertility solutions. However, challenges such as the complexity of treatment, uncertainties about success rates, and emotional stress can deter some individuals from pursuing IVF. The demand for IVF is growing particularly in developing regions, where increased awareness and better access to fertility treatments are facilitating market expansion. This presents opportunities for establishing IVF clinics and enhancing services in these areas. The ongoing technological innovations and rising demand from emerging markets represent significant growth opportunities for the IVF industry, promising improved success rates and better patient experiences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Fertilization Market Segmental Analysis

The global in vitro fertilization market is segmented based on cycle, end-user, procedure, product, and region. Based on cycle, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor. In terms of end-user, the market is segmented into Fertility Clinics & IVF Centers, Surgical Centers, Hospitals, Research Institutes, Cryobanks. Based on procedure, the market is segmented into Conventional IVF, IVF with ICSI, Minimal IVF, IVF with Donar Eggs, Others. Based on product, the market is segmented into Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators {Time-lapse incubators, Other incubators}, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices, IVF Cabinets, Anti-vibration Tables, Witness Systems), Reagents & Media (Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, Sperm Processing Media), Accessories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global In Vitro Fertilization Market

Rising awareness about infertility and the accessibility of IVF treatments have led to greater acceptance and demand for IVF procedures. As more individuals learn about these options, the stigma surrounding infertility has diminished. Public figures and celebrities who openly discuss their IVF experiences have played a crucial role in normalizing the procedure. Their stories have helped break down barriers, making IVF a more accepted and considered choice for those facing fertility challenges.

Restraints in the Global In Vitro Fertilization Market

IVF procedures raise several ethical and legal issues, including the use of donor gametes, embryo storage, and embryo selection. These concerns introduce regulatory complexities and result in differing IVF practices across various countries and regions. These variations can affect the growth and standardization of the IVF market, as different jurisdictions implement their own regulations and guidelines, leading to inconsistent practices and market dynamics.

Market Trends of the Global In Vitro Fertilization Market

In 2023, personalized medicine emerged as a significant trend in the IVF market. This approach focuses on customizing IVF treatment protocols according to individual patient factors, such as age, ovarian reserve, and specific fertility issues. The goal of personalized medicine is to enhance treatment outcomes and increase the efficiency of IVF procedures by tailoring interventions to meet the unique needs of each patient. This method aims to improve the overall effectiveness and success rates of IVF treatments.

Product Code: SQMIG35H2163

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors of The Market
  • Degree Of Competition
  • Top Investment Pockets
  • Market Attractive Index
  • Ecosystem Mapping
  • Pricing Analysis
  • Value Chain Analysis

In-Vitro Fertilization Market by Cycle

  • Fresh Non-Donor
  • Frozen Non-Donor
  • Fresh Donor
  • Frozen Donor

In-Vitro Fertilization Market by End Use

  • Fertility Clinics & IVF Centers
  • Surgical Centers
  • Hospitals
  • Research Institutes
  • Cryobanks

In-Vitro Fertilization Market by Procedure

  • Conventional IVF
  • IVF with ICSI
  • Minimal IVF
  • IVF with Donor Eggs
  • Others

In-Vitro Fertilization Market by Product

  • Equipment
    • Imaging Systems
    • Sperm Separation System
    • Ovum Aspiration Pumps
    • Micromanipulator System
    • Incubators
    • Time-lapse incubators
    • Other incubators
    • Gas Analyzers
    • Laser Systems
    • Cryosystems
    • Cabinets
    • Antivibration Tables
    • Witness Systems
    • Accessories
  • Reagents and Media
    • Embryo Culture Media
    • Cryopreservation Media
    • Sperm Processing Media
    • Ovum Processing Media

In-Vitro Fertilization Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profile

  • Vitrolife AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esco Micro Pte Ltd (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Thorne, Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nidacon International AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rocket Medical plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMD Serono (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kitazato Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IVFtech Aps (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zeiss Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labotect GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esco Medical (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Baker Company, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston IVF (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invitrocare Fertility Laboratories Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMD Serono, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!